
1. plos negl trop dis. 2020 jun 12;14(6):e0008255. doi:
10.1371/journal.pntd.0008255. ecollection 2020 jun.

ex vivo susceptibilities plasmodium vivax isolates china-myanmar
border antimalarial drugs association polymorphisms pvmdr1 and
pvcrt-o genes.

li j(1)(2), zhang j(3), li q(1)(4), hu y(3), ruan y(5), tao z(1)(2), xia h(1)(2),
qiao j(1)(2), meng l(1)(2), zeng w(3), li c(3), x(3), zhao l(3), siddiqui
fa(6), miao j(6), yang z(3), fang q(1)(2), cui l(6).

author information: 
(1)department microbiology parasitology, bengbu medical college, bengbu,
anhui province, china.
(2)anhui key laboratory infection immunity, bengbu medical college,
bengbu, anhui province, china.
(3)department pathogen biology immunology, kunming medical university,
kunming, yunnan province, china.
(4)xiangtan blood center, xiangtan, hunan province, china.
(5)department pathology, kunming medical university, kunming, yunnan province,
china.
(6)department internal medicine, morsani college medicine, university of
south florida, tampa, florida, united states america.

background: vivax malaria important public health problem greater
mekong subregion (gms), including china-myanmar border. previous studies have
found plasmodium vivax decreased sensitivity antimalarial drugs in
some areas gms, sensitivity p. vivax antimalarial drugs is
unclear china-myanmar border. here, investigate drug sensitivity
profile genetic variations two drug resistance related genes p. vivax 
isolates provide baseline information future drug studies the
china-myanmar border.
methodology/principal findings: total 64 p. vivax clinical isolates
collected china-myanmar border area assessed ex vivo
susceptibility eight antimalarial drugs schizont maturation assay. 
medians ic50 (half-maximum inhibitory concentrations) chloroquine,
mefloquine, pyronaridine, piperaquine, quinine, artesunate, artemether,
dihydroartemisinin 84.2 nm, 34.9 nm, 4.0 nm, 22.3 nm, 41.4 nm, 2.8 nm, 2.1
nm 2.0 nm, respectively. twelve p. vivax clinical isolates found over
the cut-off ic50 value (220 nm) chloroquine resistance. addition, sequence
polymorphisms pvmdr1 (p. vivax multidrug resistance-1), pvcrt-o (p. vivax
chloroquine resistance transporter-o), difference pvmdr1 copy number 
studied. sequencing pvmdr1 gene 52 samples identified 12 amino acid
substitutions, among two (g698s t958m) fixed, m908l present
in 98.1% isolates, y976f f1076l present 3.8% 78.8%
of isolates, respectively. amplification pvmdr1 gene detected
in 4.8% samples. sequencing pvcrt-o 59 parasite isolates
identified single lysine insertion position 10 32.2% isolates. the
pvmdr1 m908l substitutions pvmdr1 samples associated reduced
sensitivity chloroquine, mefloquine, pyronaridine, piperaquine, quinine,
artesunate dihydroartemisinin.
conclusions: findings depict drug sensitivity profile genetic
variations p. vivax isolates china-myanmar border area, and
suggest possible emergence chloroquine resistant p. vivax isolates the
region, demands efforts resistance monitoring mechanism
studies.

doi: 10.1371/journal.pntd.0008255 
pmcid: pmc7314094
pmid: 32530913  [indexed medline]

conflict interest statement: authors declared competing
interests exist.

